GMED 250117 87.50C (GMED250117C87500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

GMED250117C87500

Watchlist

0.58
-0.12-17.14%

15min DelayClose Dec 31 16:00 ET

0.60High0.58Low

Intraday

5D
Daily

News

Reasons to Add GMED Stock to Your Portfolio Right Now
Zacks Dec 24, 2024 07:00 ET
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?
Zacks Dec 19, 2024 12:00 ET
Investors in Globus Medical (NYSE:GMED) Have Seen Notable Returns of 58% Over the Past Year
Simply Wall StDec 19, 2024 08:26 ET
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $101
Moomoo NewsDec 19, 2024 05:33 ET · Ratings
Piper Sandler Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Moomoo NewsDec 18, 2024 18:31 ET · Ratings
Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)
TipRanksDec 18, 2024 16:15 ET · Ratings

Comments

whqqq

Aug 8, 2024 01:51

Arm Holdings, Upstart, Globus Medical Get Analyst Cheer, Retail Bullish On Just Two Names

Retail investors are positive about Upstart and Globus Medical but remain undecided on Arm Holdings as guidance remains sluggish.
Wall Street started Wednesday positively, with major indices rising nearly 1%. Analysts have added to the optimism with upgrades in the semiconductor, financials, and healthcare sectors. Here’s what Bernstein, Citi, and Wells Fargo analysts think:
1. Arm Holdings ( $Arm Holdings (ARM.US)$ ): ...

Moomoo AI

Feb 5, 2024 19:27

The company's CEO, Dan Scavilla, expressed confidence in Pfeil's ability to drive operational efficiency and deliver profitable growth, especially in light of the ongoing integration following their merger with NuVasive.

Press Release: Globus Medical Promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer

Moomoo AI

Dec 22, 2023 07:10

Globus Medical's superior earnings outlook is contributing to its high P/E, which shareholders are currently comfortable with, expecting not to face a threat to future earnings. The confidence in the future earnings performance supports the current share price.

Why Investors Shouldn't Be Surprised By Globus Medical, Inc.'s (NYSE:GMED) P/E

Moomoo AI

Nov 9, 2023 08:06

Globus Medical's persisting issues impact its valuation and a drop in EPS may spark shareholder worry. The long-term share performance is lackluster, unsettling even potential contrarian investors seeking a turnaround.

Shareholders in Globus Medical (NYSE:GMED) Are in the Red If They Invested a Year Ago

TRIUMPHANT RETURNS

Oct 17, 2023 12:02

on track to 65 ...yeeha.

$SPDR S&P Biotech ETF (XBI.US)$ $Intuitive Surgical (ISRG.US)$ $ResMed (RMD.US)$ $Thermo Fisher Scientific (TMO.US)$ $Boston Scientific (BSX.US)$ $Coinbase (COIN.US)$ $Charles Schwab (SCHW.US)$